Jakson kuvaus
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
Two injections a year instead of a daily pill. Sounds like a big win for HIV prevention, but will it actually reach the people who need it? And what should happen to a medicine the moment a lab says it failed? In this episode of Pharma Explained, we break down both.
We’ll cover:
• What a tentative US FDA approval means for Dr. Reddy’s generic HIV prevention injection.
• Why the partners expect a price of $40 per person per year.
• How India’s draft rule could let regulators suspend a…
Sivusto: rss.com

